• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [6756 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2016 Haute Autorite de sante (HAS) [Evaluation of gene amplification for diagnosis Herpesviridae infections (cytomegalovirus, herpes simplex virus and varicella-zoster) in people living with HIV]
2016 NIHR Health Technology Assessment programme Tumour necrosis factor- inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation
2016 NIHR Health Services and Delivery Research programme Cross-national comparative mixed-methods case study of recovery-focused mental health care planning and co-ordination: Collaborative Care Planning Project (COCAPP)
2016 NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial
2016 NIHR Health Technology Assessment programme Intervention Now to Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, and qualitative and realist synthesis of implementation factors and user engagement
2016 NIHR Health Services and Delivery Research programme Development of risk models for the prediction of new or worsening acute kidney injury on or during hospital admission: a cohort and nested study
2016 NIHR Health Services and Delivery Research programme Comparing the cost-effectiveness and clinical effectiveness of a new community in-reach rehabilitation service with the cost-effectiveness and clinical effectiveness of an established hospital-based rehabilitation service for older people: a pragmatic randomised controlled trial with microcost and qualitative analysis – the Community In-reach Rehabilitation And Care Transition (CIRACT) study
2016 NIHR Health Services and Delivery Research programme Comorbidity and dementia: a mixed-method study on improving health care for people with dementia (CoDem)
2016 NIHR Health Services and Delivery Research programme Management by geographical area or management specialised by disorder? A mixed-methods evaluation of the effects of an organisational intervention on secondary mental health care for common mental disorder
2016 NIHR Horizon Scanning Centre (NIHR HSC) Daratumumab with bortezomib and dexamethasone for relapsed or refractory multiple myeloma – second line
2016 NIHR Horizon Scanning Centre (NIHR HSC) IMA-901 for locally advanced or metastatic renal cell carcinoma ─ first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Alicaforsen for active ulcerative colitis – second line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Fenfluramine for Dravet syndrome – first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Guselkumab for moderate to severe psoriasis
2016 NIHR Horizon Scanning Centre (NIHR HSC) Doxorubicin-eluting beads (DC Bead, DC Bead M1 and Radiopaque DC Bead) for hepatocellular carcinoma
2016 NIHR Horizon Scanning Centre (NIHR HSC) Cytovir CMV for cytomegalovirus infection in patients undergoing allogeneic haematopoietic stem cell transplantation
2016 NIHR Horizon Scanning Centre (NIHR HSC) Lenvatinib in combination with everolimus for advanced or metastatic renal cell carcinoma – second line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for follicular non-Hodgkin lymphoma ─ third line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Ibrutinib (Imbruvica) with bendamustine and rituximab for chronic lymphocytic leukaemia or small lymphocytic lymphoma – second line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for metastatic or unresectable urothelial bladder cancer – second line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Obinutuzumab (Gazyvaro) with bendamustine for chronic lymphocytic leukaemia ─ first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) LentiGlobin BB305 (LentiGlobin) for beta-thalassaemia major – first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Ibrutinib (Imbruvica) with R-CHOP for diffuse large B-cell lymphoma – first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Afatinib (Giotrif) for advanced or metastatic, squamous non-small cell lung cancer progressing on or after platinum-based chemotherapy
2016 NIHR Horizon Scanning Centre (NIHR HSC) Triptorelin (Decapeptyl SR) for premenopausal women with early endocrine responsive breast cancer
2016 NIHR Horizon Scanning Centre (NIHR HSC) Pegpleranib (Fovista) for neovascular age-related macular degeneration
2016 NIHR Horizon Scanning Centre (NIHR HSC) Idebenone (Raxone) for Duchenne muscular dystrophy – first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Ibrutinib (Imbruvica) for relapsed and refractory marginal zone lymphoma – second or subsequent line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Binimetinib for recurrent or persistent ovarian, fallopian tube or primary peritoneal cancer ─ second and subsequent line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Pexiganan (Locilex) for mild foot infection in diabetic foot ulcers
2016 NIHR Horizon Scanning Centre (NIHR HSC) Subcutaneous tocilizumab for juvenile idiopathic polyarthritis – second line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Oxecam for health monitoring in secure mental health facilities
2016 NIHR Horizon Scanning Centre (NIHR HSC) Neon EEG for monitoring neonatal seizures
2016 NIHR Horizon Scanning Centre (NIHR HSC) ReActiv8® implantable device for treating chronic low back pain
2016 NIHR Horizon Scanning Centre (NIHR HSC) AVATAR therapy for auditory verbal hallucinations in psychosis
2016 NIHR Horizon Scanning Centre (NIHR HSC) myPlan™ test for early-stage lung adenocarcinoma prognosis
2016 NIHR Public Health Research (PHR) programme Community pharmacy interventions for public health priorities: a systematic review of community pharmacy-delivered smoking, alcohol and weight management interventions
2016 NIHR Horizon Scanning Centre (NIHR HSC) Nintedanib (Vargatef) for metastatic colorectal cancer – second and subsequent line
2016 NIHR Horizon Scanning Centre (NIHR HSC) NBTXR-3 for advanced soft tissue sarcoma – first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for advanced or metastatic malignant melanoma with a c-kit juxtamembrane mutation
2016 NIHR Horizon Scanning Centre (NIHR HSC) Olaparib (Lynparza) for metastatic breast cancer with germline BRCA mutation – second line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for stage IV or recurrent PD-L1 positive non-small cell lung cancer – first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for stage IV or recurrent non-small cell lung cancer – first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Rucaparib for advanced BRCA-mutated ovarian cancer
2016 NIHR Horizon Scanning Centre (NIHR HSC) Reolysin for relapsed or refractory multiple myeloma
2016 NIHR Horizon Scanning Centre (NIHR HSC) Pembrolizumab (Keytruda) for platinum-resistant, recurrent or metastatic head and neck cancer
2016 NIHR Horizon Scanning Centre (NIHR HSC) AM-111 for acute sensorineural hearing loss - first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Tremelimumab for unresectable pleural or peritoneal malignant mesothelioma – second and third line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Selumetinib with radioactive iodine therapy for differentiated thyroid cancer – first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Eteplirsen for Duchenne muscular dystrophy in patients amenable to exon 51 skipping
2016 NIHR Horizon Scanning Centre (NIHR HSC) DMI-9523 (Ampion) for moderate to severe osteoarthritis of the knee
2016 NIHR Horizon Scanning Centre (NIHR HSC) SPK-RPE65 gene therapy for inherited retinal dystrophies due to mutations in the RPE65 gene
2016 NIHR Horizon Scanning Centre (NIHR HSC) Lebrikizumab for severe asthma – second line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Pitolisant hydrochloride for obstructive sleep apnoea
2016 NIHR Horizon Scanning Centre (NIHR HSC) Ace-ER (aceneuramic acid - extended release) for GNE myopathy
2016 NIHR Health Services and Delivery Research programme Preparing for Home: a before-and-after study to investigate the effects of a neonatal discharge package aimed at increasing parental knowledge, understanding and confidence in caring for their preterm infant before and after discharge from hospital
2016 Agency for Healthcare Research and Quality (AHRQ) Management of gout
2016 Agency for Healthcare Research and Quality (AHRQ) Calcineurin inhibitors for renal transplant
2016 Agency for Healthcare Research and Quality (AHRQ) Noninvasive treatments for low back pain
2016 Agency for Healthcare Research and Quality (AHRQ) Management of renal masses and localized renal cancer
2016 Agency for Healthcare Research and Quality (AHRQ) Home-based primary care interventions
2016 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Thrombectomy for ischaemic stroke: patient characteristics, structural requirements and (differential) diagnostics]
2016 Health Quality Ontario (HQO) Intrathecal drug delivery systems for cancer pain: a health technology assessment
2016 Health Quality Ontario (HQO) Intrathecal drug delivery systems for noncancer pain: a health technology assessment
2016 Health Quality Ontario (HQO) Left ventricular assist devices for destination therapy: a health technology assessment
2016 Health Quality Ontario (HQO) Mechanical thrombectomy in patients with acute ischemic stroke: a health technology assessment
2016 Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment- resistant depression: a systematic review and meta-analysis of randomized controlled trials
2016 Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment-resistant depression: an economic analysis
2016 Health Quality Ontario (HQO) Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: a clinical evidence review
2016 Health Quality Ontario (HQO) Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: an economic analysis
2016 Health Quality Ontario (HQO) Intrathecal drug delivery systems for cancer pain and noncancer pain: OHTAC recommendation
2016 Health Quality Ontario (HQO) Left ventricular assist devices for destination therapy: OHTAC recommendation
2016 Health Quality Ontario (HQO) Mechanical thrombectomy for patients with acute ischemic stroke: OHTAC recommendation
2016 Health Quality Ontario (HQO) Repetitive transcranial magnetic stimulation for treatment-resistant depression: OHTAC recommendation
2016 Health Quality Ontario (HQO) Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: OHTAC recommendation
2016 Technology Assessment at SickKids (TASK) A microcosting and cost-consequence analysis of genomic testing strategies in autism spectrum disorder
2016 NIHR Health Technology Assessment programme Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): a randomised controlled trial with cost-effectiveness analysis
2016 NIHR Health Technology Assessment programme The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection
2016 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ofatumumab (Arzerra®) as maintenance therapy in patients with relapsed chronic lymphocytic leukaemia (CLL)
2016 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) in previously treated advanced non-small cell lung cancer (NSCLC)
2016 NIHR Public Health Research (PHR) programme Change in alcohol outlet density and alcohol-related harm to population health (CHALICE): a comprehensive record-linked database study in Wales
2016 NIHR Health Technology Assessment programme EQUATOR Network
2016 Agency for Healthcare Research and Quality (AHRQ) Noninvasive testing for coronary artery disease
2016 Agency for Healthcare Research and Quality (AHRQ) Improving cultural competence to reduce health disparities
2016 Agency for Healthcare Research and Quality (AHRQ) Early diagnosis, prevention, and treatment of Clostridium difficile: update
2016 Agency for Healthcare Research and Quality (AHRQ) Data linkage strategies to advance youth suicide prevention
2016 Agency for Healthcare Research and Quality (AHRQ) Nonpharmacologic interventions for agitation and aggression in dementia
2016 Agency for Healthcare Research and Quality (AHRQ) Treatments for fecal incontinence
2016 Agency for Healthcare Research and Quality (AHRQ) Treatment strategies for patients with lower extremity chronic venous disease (LECVD)
2016 Agency for Healthcare Research and Quality (AHRQ) Retinal prostheses in the Medicare population
2016 Agency for Healthcare Research and Quality (AHRQ) Renal denervation in the Medicare Population
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Levels of care: norms and quality standards]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Localized prostate cancer: effectiveness and safety of treatment options]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Use of the Oncotype DX® test for therapeutic decision-making in the context of treating invasive breast cancer]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Tonsil surgery: comparison of intracapsular dissections and extracapsular dissections and dentification of children at risk for hemorrhage]
2016 NIHR Health Technology Assessment programme The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis
2016 NIHR Health Services and Delivery Research programme Do-not-attempt-cardiopulmonary-resuscitation decisions: an evidence synthesis
2016 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) for diffuse large B-cell lymphoma – maintenance therapy
2016 NIHR Horizon Scanning Centre (NIHR HSC) Dabrafenib (Tafinlar) and trametinib (Mekinist) combination therapy for advanced BRAF mutated non-small cell lung cancer
2016 NIHR Horizon Scanning Centre (NIHR HSC) ADI-PEG 20 for hepatocellular carcinoma – second line